申请人:Parke, Davis & Company
公开号:US04112103A1
公开(公告)日:1978-09-05
(+,-)-cis-.alpha.[3-(2,6-Dimethyl-1-piperidinyl)propyl]-.alpha.-phenyl-2-py ridinemethanol and acid-addition salts. The compounds are pharmacological agents, especially antiarrhythmic agents. The compounds can be produced by reacting pyridyllithium with cis-.gamma.-(2,6-dimethylpiperidino)butyrophenone, or by reacting cis-1-(3-lithiopropyl)-2,6-dimethylpiperidine with 2-benzoylpyridine. Pharmaceutical compositions comprising (+,-)-cis-.alpha.-[3-(2,6-dimethyl-1-piperidinyl)propyl]-.alpha.-phenyl-2- pyridinemethanol and acid-addition salts thereof and methods for treating cardiac arrhythmia using said pharmaceutical compositions are also disclosed.
(+,-)-顺式-.alpha.[3-(2,6-二甲基-1-哌啶基)丙基]-.alpha.-苯基-2-吡啶甲醇及其酸盐是药理学药剂,尤其是抗心律失常药剂。该化合物可以通过将吡啶基锂与顺式-.gamma.-(2,6-二甲基哌啶基)丁酮苯反应来制备,或通过将顺式-1-(3-锂丙基)-2,6-二甲基哌啶与2-苯甲酰吡啶反应来制备。还公开了包含(+,-)-顺式-.alpha.-[3-(2,6-二甲基-1-哌啶基)丙基]-.alpha.-苯基-2-吡啶甲醇及其酸盐的制药组合物以及使用该制药组合物治疗心律失常的方法。